Symbol
ALGS on Nasdaq
Investment type
Equity / Voting Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned
289,169 shares
Security Ownership %
5.4%
Shares, Excluding Options vs Price
Value, Excluding Options

Woodline Partners LP ownership in Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (ALGS)

17 Feb 2026 - Woodline Partners LP has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 289,169 shares of Aligos Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (ALGS). This represents 5.4% ownership of the company. In their previous filing dated 14 Nov 2025, Woodline Partners LP had reported owning 468,199 shares, indicating a decrease of +38%. .
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.